Aclaris Therapeutics所有資訊

Aclaris Therapeutics | 4：持股變動聲明-高管 Walker Neal

05/03 16:26 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Walker Neal

04/03 17:05 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Balthaser Kevin

03/05 17:13 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Monahan Joseph

03/05 17:12 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Walker Neal

03/05 17:09 (美東)

Aclaris Therapeutics | 4：持股變動聲明-董事 Powell Andrew Kenneth William

03/05 17:05 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%)等

02/14 20:33 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等

02/14 17:30 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Kenneth Griffin(7.6%),Citadel Advisors LLC(6.1%)等

02/14 17:05 (美東)

Aclaris Therapeutics | SC 13G：超過5%持股股東披露文件-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%)等

02/14 16:22 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(2.5%),Tang Capital Management, LLC(2.5%)等

02/14 16:03 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Rock Springs Capital Management LP(4.23%),Rock Springs Capital LLC(4.23%)等

02/14 15:51 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 10:32 (美東)

Aclaris Therapeutics | SC 13G：超過5%持股股東披露文件-The Vanguard Group(6.67%)

02/13 18:18 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Foresite Capital Fund IV, L.P. (“FCF IV”)(0.0%),Foresite Capital Management IV, LLC (“FCM IV”)(0.0%)等

02/13 14:26 (美東)

Aclaris Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BML Investment Partners, L.P.(13.3%)

02/08 11:20 (美東)

Aclaris Therapeutics | 3：首次持股聲明-股東 Leonard Braden Michael

02/08 10:50 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Walker Neal

02/05 19:39 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Monahan Joseph

02/05 19:34 (美東)

Aclaris Therapeutics | 4：持股變動聲明-高管 Loerop James

02/05 19:34 (美東)